Screener
Embecta Corp.
EMBCEmbecta is a leading global medical device company dedicated to improving the lives of people living with diabetes through advanced injection technologies.
Earnings
Next report
Nov 24, 2026 (in 2 months)Revenue estimate$269.7M
EPS estimate$0.31
Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
Embecta is a leading global medical device company dedicated to improving the lives of people living with diabetes through advanced injection technologies. The company provides a comprehensive portfolio of insulin delivery solutions, including pen needles and syringes, used by millions of patients worldwide. Leveraging a century-long heritage, the company focuses on enhancing patient comfort, safety, and ease of use in daily diabetes management.
Competitive position
A global leader in diabetes injection devices with a 100-year heritage and products used by over 30 million people.
GeographiesUnited States, China, Ireland, Global
Customer segmentsPatients, Healthcare Providers, Retailers
Business modelManufacturing, Direct-to-Consumer, B2B
SuppliersCannula suppliers, Plastic resin suppliers, Adhesive and lubricant manufacturers, Rubber stopper suppliers, Packaging material providers
CustomersRetail pharmacies, Hospitals, Institutional healthcare channels, End-user patients with diabetes
CountryUnited States of America
Listed2022
Employees2.2K
CEODevdatt Kurdikar
SectorHealthcare
Websiteembecta.com
FilingsSEC EDGAR
FAQ
- What is Embecta Corp.'s market cap?
- Embecta Corp. (EMBC) has a market capitalization of $290.7M and trades on NASDAQ.
- What is Embecta Corp.'s revenue and profitability?
- Embecta Corp. generated $1.0B in trailing twelve-month revenue with net income of $87.5M, representing a net margin of 8.6%. Gross margin stands at 59.0%, with free cash flow of $164.6M. The latest reported period is Q3 2026.
- Who are Embecta Corp.'s competitors?
- Embecta Corp.'s key competitors include Tandem Diabetes Care, Insulet Corporation, Medtronic, and others. These companies compete in similar markets and product categories.
- Who does Embecta Corp. partner with?
- Embecta Corp.'s notable partners include Becton, Dickinson and Company.
- Where is Embecta Corp. headquartered?
- Embecta Corp. is headquartered in United States of America and employs approximately 2,200 people. It has been publicly traded since 2022.
